U.S. Life Sciences Stock News

If you are wondering whether Badger Meter at around US$121.98 is pricing in too much optimism or leaving some value on the table, this breakdown will help you frame that question clearly. The stock has been under pressure recently, with a 0.1% return over 7 days, a 22.2% decline over 30 days, and year to date and 1 year returns of 30.8% and 46.4% declines, even though the 5 year return still sits at 37.9%. These moves have pushed Badger Meter firmly onto the radar of investors rethinking...

Investors may be wondering whether Valaris at around US$102 a share still offers value, or if most of the opportunity is already priced in. The recent share price of US$102.23 comes after returns of 12.1% over the last 7 days, 4.3% over 30 days, 96.0% year to date and 184.3% over the past year. This naturally raises questions about how much upside or risk is now built into the stock. Recent coverage has focused on Valaris as a key name in offshore drilling and contract drilling services,...

IES Holdings (IESC) has just posted another solid update, with Q1 2026 revenue at US$871 million and basic EPS of US$4.58, backed by trailing twelve month revenue of about US$3.5 billion and EPS of US$17.04. Over the past year, revenue has moved from US$3.0 billion to US$3.5 billion while EPS has risen from US$10.89 to US$17.04, reflecting a step up in earnings power that sits alongside a higher net profit margin. For investors, the key takeaway is that profitability has become more...

CNX Resources (NYSE:CNX) is expanding its Utica development and updating its long-term Marcellus plan to align with rising in-basin demand from large-scale power and data center projects. The company has completed a major refinancing of long-term notes and finalized the conversion of its remaining convertible notes, changing the structure of its balance sheet. CNX has also added to its long-dated hedging program, seeking to manage exposure to natural gas price differentials over an extended...

Alpine Banks of Colorado (ALPI.B) opened Q1 2026 earnings season with Q4 2025 revenue of US$73.3 million and basic EPS of US$1.23, supported by quarterly net income of US$19.8 million. Over the past six reported quarters, revenue has ranged from US$59.2 million to US$73.3 million while basic EPS has moved between US$0.74 and US$1.73. This gives a clear view of how the top line and EPS have tracked together across 2024 and 2025. With trailing net profit margin at 25.9% versus 21.2% a year...

Wondering whether Insmed at US$133.26 is offering fair value or stretching expectations? This article walks through how the current price stacks up against several valuation yardsticks. The stock has had a mixed run recently, with a 1.4% decline over the last 7 days, an 18.0% decline over 30 days, and a 24.8% decline year to date, set against an 84.3% return over the past year and a very large return over three years. These moves sit against a backdrop of ongoing interest in the biotech...

Applied Industrial Technologies (NYSE:AIT) announced a new share repurchase program. The authorization covers the buyback of up to 3,000,000 shares. Applied Industrial Technologies focuses on industrial distribution and related services, supplying components and solutions to a wide range of end markets. Share repurchase authorizations of this size can matter for investors who watch how companies balance cash uses between growth, acquisitions, dividends, and buybacks. For you as a...

Investors may be wondering if Ichor Holdings at around US$64.42 is still offering value, or if most of the opportunity is already priced in. The stock has seen a 33.9% gain over the last 30 days and a 215.6% return year to date, with 206.9% over the past year and 126.1% over three years. These figures can change how investors view both its potential and its risks. Recent attention on semiconductor related names, including Ichor Holdings, has highlighted themes such as supply chain...

Ares Management Q1 2026 Earnings Snapshot Ares Management (ARES) has opened 2026 earnings season with Q1 results that sit against a backdrop of trailing 12 month revenue of about US$5.6 billion and basic EPS of US$2.16, alongside net income of roughly US$468.7 million. Over the past year, revenue has stepped up from about US$3.9 billion in the period ending Q4 2024 to US$5.6 billion most recently, while basic EPS has moved from US$2.38 to US$2.16. This gives investors a clearer view of how...

Empire State Realty Trust (NYSE:ESRT) is marking the Empire State Building’s 95th anniversary with new observation deck experiences and special events. The company recently completed a US$165 million remodel aimed at improving the visitor journey and on site amenities. The building has achieved LEED v5 Platinum certification and is targeting net zero emissions for 2030, highlighting a focus on sustainability. For investors watching NYSE:ESRT, this anniversary is more than a birthday...

If you are wondering whether Guardian Pharmacy Services at US$37.37 still offers value after a strong run, the next sections will walk through what the current price could be implying. The stock has slipped 0.5% over the last 7 days and 1.6% over the last 30 days, yet it is still up 26.5% year to date and 44.9% over the past year, which may have shifted how some investors view its risk and reward trade off. Recent attention on Guardian Pharmacy Services has largely centered on its role...

Why Mechanics Bancorp (MCHB) is on investors’ radar Mechanics Bancorp (MCHB) has attracted fresh attention after recent share price moves, with the stock up about 1% over the past day but slightly lower over the past week and past 3 months. See our latest analysis for Mechanics Bancorp. While the share price has eased over the past week and quarter, the 1-year total shareholder return of 70.51% and 5-year total shareholder return of 166.71% indicate strong momentum over a longer horizon...

If you are wondering whether Carvana's current share price lines up with its underlying value, this breakdown will help you connect the recent moves in the stock to what the numbers actually say. Carvana recently closed at US$382.60, with returns of 21.9% over 30 days, a 6.5% decline over 7 days, a 4.4% decline year to date, and a 48.8% return over 1 year. The 3 year return is very large. Recent news coverage has focused on Carvana's position in online used car retailing and the market's...

If you are wondering whether Daqo New Energy's current share price reflects its true worth, it helps to start with how the market has been treating the stock lately. The shares last closed at US$19.14, with returns of a 16.7% decline over 7 days, a 9.3% decline over 30 days, and a 35.5% decline year to date, contrasted with a 48.5% gain over the past year and larger declines of 57.2% and 74.4% over 3 and 5 years. These moves have played out against a backdrop of ongoing interest in the solar...

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...

Brookfield Infrastructure Corporation reported first-quarter 2026 results showing sales of US$884 million versus US$929 million a year earlier, and a net loss of US$112 million compared with prior-year net income of US$389 million, while affirming a quarterly dividend of US$0.4550 per share payable on June 30, 2026. Beneath the weaker accounting earnings, management highlighted a 10% increase in funds from operations, progress toward about US$1 billion of capital recycling, and a 6% dividend...

If you are wondering whether Genius Sports at US$4.35 is a bargain or a value trap, the starting point is to understand what the current share price is really pricing in. The stock has seen a 2.7% decline over the last week, a 4.6% decline over the last month and a 59.6% decline year to date, while the 1 year return is a 60.6% loss and the 5 year return is a 76.8% loss, with only the 3 year period showing an 8.2% gain. These moves sit against a backdrop of ongoing attention on sports data,...

If you are wondering whether Aramark’s current share price reflects its true value, the next sections walk through what the numbers actually say about the stock. Aramark shares last closed at US$44.95, with returns of 5.6% over 30 days, 22.9% year to date and 35.2% over 1 year, which has many investors reassessing both its potential and its risks. Over the past year Aramark has been in the spotlight as investors have tracked its performance and repositioned their expectations for the...

Moderna (MRNA) opened 2026 with Q1 results that continue the recent trend of revenue and losses sitting side by side, with trailing 12 month revenue at US$1.9 billion and a basic EPS loss of US$7.25 per share tied to a net loss of US$2.8 billion. Over recent quarters, the company has seen quarterly revenue move between US$108 million and US$1.9 billion with basic EPS ranging from a small profit of US$0.03 per share in Q3 2024 to losses of more than US$2.50 per share in several 2025 quarters,...

If you are wondering whether Snap at around US$6.29 is a bargain or a value trap, the key is understanding what the current price actually reflects about its future. The share price has moved sharply in the short term, with returns of 11.3% over the last 7 days and 35.9% over the last 30 days, set against a year to date return of negative 22.6% and a 1 year return of negative 25.6%. These moves come as Snap continues to sit in the spotlight of investors who are weighing its long term...

Piper Sandler Companies (PIPR) has entered Q1 2026 with trailing 12 month revenue of about US$1.9b and basic EPS of US$4.22. This is alongside year over year earnings growth of 55.3% and revenue growth of 9.8%. Over the past reported quarters, total revenue has moved from US$484.1 million in Q4 2024 to US$666.1 million in Q4 2025, while quarterly basic EPS has ranged from US$0.55 in Q3 2024 to US$1.69 in Q4 2025. Taken together, these figures present a picture of improving profitability and...

Tyler Technologies (NYSE:TYL) has completed its third largest acquisition, For The Record, adding court recording and transcription technology to its portfolio. The company has updated revenue guidance to reflect FTR and is leaning on the deal to support its shift toward cloud and AI-enabled solutions. Tyler is advancing its cloud migration plan, targeting nearly all new public safety clients and 80% of on premise customers to be in the cloud by 2030. For Tyler Technologies, a long time...

If you are wondering whether Dorman Products is attractively priced or looking stretched at around US$112.88, this article walks through the numbers that matter for valuation. The stock price sits at US$112.88, with returns of 1.5% over the last week, 11.9% over the last month, a 9.0% decline year to date, and a 2.1% decline over the last year. These returns are set against 27.7% and 8.1% over the past 3 and 5 years. Recent news coverage has focused on Dorman Products in the context of...